Bioporto A/S
CSE:BIOPOR
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.222
2.965
|
Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one BIOPOR stock under the Base Case scenario is 1.257 DKK. Compared to the current market price of 1.624 DKK, Bioporto A/S is Overvalued by 23%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Bioporto A/S
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for BIOPOR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Bioporto A/S
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Bioporto A/S
Balance Sheet Decomposition
Bioporto A/S
Current Assets | 123.9m |
Cash & Short-Term Investments | 103.9m |
Receivables | 13.4m |
Other Current Assets | 6.6m |
Non-Current Assets | 7.7m |
Long-Term Investments | 1.3m |
PP&E | 1.1m |
Intangibles | 346k |
Other Non-Current Assets | 4.9m |
Current Liabilities | 23.2m |
Accounts Payable | 5.5m |
Accrued Liabilities | 15.4m |
Other Current Liabilities | 2.3m |
Non-Current Liabilities | 3.5m |
Long-Term Debt | 3.5m |
Earnings Waterfall
Bioporto A/S
Revenue
|
33.8m
DKK
|
Cost of Revenue
|
-9.8m
DKK
|
Gross Profit
|
24.1m
DKK
|
Operating Expenses
|
-82m
DKK
|
Operating Income
|
-57.9m
DKK
|
Other Expenses
|
7.9m
DKK
|
Net Income
|
-50m
DKK
|
Free Cash Flow Analysis
Bioporto A/S
DKK | |
Free Cash Flow | DKK |
BIOPOR Profitability Score
Profitability Due Diligence
Bioporto A/S's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
Bioporto A/S's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
BIOPOR Solvency Score
Solvency Due Diligence
Bioporto A/S's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Bioporto A/S's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BIOPOR Price Targets Summary
Bioporto A/S
According to Wall Street analysts, the average 1-year price target for BIOPOR is 3.06 DKK with a low forecast of 3.03 DKK and a high forecast of 3.15 DKK.
Dividends
Current shareholder yield for BIOPOR is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Bioporto A/S engages in the provision of diagnostic tests and antibodies to healthcare professionals in clinical and research settings. The Company’s portfolio comprises five product categories: The Neutrophil gelatinase-associated lipocalin (NGAL) Test, which is a test for diagnosing acute kidney injury; NGAL Enzyme-linked immunosorbent assay (ELISA) kits, which supplies NGAL for the development of medicines for estimating side-effects that are harmful to kidneys; Mannan-binding Lectin (MBL) ELISA kit, which offers monoclonal MBL antibodies that are responsible for the activation of immune response; Antibodies, including monoclonal antibodies used in a range of research areas, such as microbiology, biomarkers, peptide hormones and plasma proteins; and Activated Protein C with Protein C Inhibitor Complex (APC-PCI), a biomarker applied to patients with sepsis and thrombotic and hemostatic disorders. In addition, the Company is a parent of BioPorto Diagnostics A/S.
Officers
The intrinsic value of one BIOPOR stock under the Base Case scenario is 1.257 DKK.
Compared to the current market price of 1.624 DKK, Bioporto A/S is Overvalued by 23%.